- Home
- CTNM vs COYA Comparison
CTNM vs COYA Comparison
Compare CTNM & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- COYA
- Stock Information
- Founded
- CTNM 2009
- COYA 2020
- Country
- CTNM United States
- COYA United States
- Employees
- CTNM N/A
- COYA N/A
- Industry
- CTNM
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- CTNM
- COYA Health Care
- Exchange
- CTNM Nasdaq
- COYA Nasdaq
- Market Cap
- CTNM 114.1M
- COYA 103.2M
- IPO Year
- CTNM 2024
- COYA 2022
- Fundamental
- Price
- CTNM $3.51
- COYA $5.93
- Analyst Decision
- CTNM Strong Buy
- COYA Strong Buy
- Analyst Count
- CTNM 4
- COYA 4
- Target Price
- CTNM $23.75
- COYA $17.00
- AVG Volume (30 Days)
- CTNM 83.1K
- COYA 66.8K
- Earning Date
- CTNM 05-14-2025
- COYA 05-13-2025
- Dividend Yield
- CTNM N/A
- COYA N/A
- EPS Growth
- CTNM N/A
- COYA N/A
- EPS
- CTNM N/A
- COYA N/A
- Revenue
- CTNM N/A
- COYA $3,685,107.00
- Revenue This Year
- CTNM N/A
- COYA $94.45
- Revenue Next Year
- CTNM N/A
- COYA N/A
- P/E Ratio
- CTNM N/A
- COYA N/A
- Revenue Growth
- CTNM N/A
- COYA N/A
- 52 Week Low
- CTNM $3.69
- COYA $4.65
- 52 Week High
- CTNM $22.00
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- COYA 48.29
- Support Level
- CTNM N/A
- COYA $5.63
- Resistance Level
- CTNM N/A
- COYA $6.53
- Average True Range (ATR)
- CTNM 0.00
- COYA 0.46
- MACD
- CTNM 0.00
- COYA -0.03
- Stochastic Oscillator
- CTNM 0.00
- COYA 29.70
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.